# M0.6.5 Convergence Trigger — SIG-20260615-71775d0a

## 1. Primary Trigger

| Field | Value |
|---|---|
| trigger_name | HONA first standalone quarterly earnings release (Q2 FY2026) |
| trigger_date_range | Late July 2026 — approximately July 22–31, 2026. Basis: Honeywell reported Q1 FY2026 results on April 24, 2026 [Honeywell Q1 FY2026 8-K, SEC EDGAR, April 24, 2026]; the prior-year Q2 FY2025 release was July 24, 2025 [Honeywell investor calendar pattern, web search June 15, 2026, unverified]. Q2 FY2026 (April–June) results are expected in the same window, now reported by HONA as a stand-alone registrant for the first time. No exact date has been announced by HONA's investor relations as of June 15, 2026. |
| trigger_type | scheduled |
| probability_if_unscheduled | null |
| probability_note | A public company is legally required to file its quarterly results with the SEC (Form 10-Q) within 40 days of quarter-end (June 30, 2026), placing the outer deadline at August 9, 2026. The report will happen; the exact date within the late-July to August 9 window is not yet confirmed. [SEC Regulation S-X Rule 10-01(a)(8), 40-day filing requirement for large accelerated filers] |
| Inside M0.4 horizon? | Yes — M0.4 expiry is September 7, 2026; late-July earnings lands well inside it. |

**Pre-trigger partial convergence event:** HONA opens for regular-way trading on Nasdaq on June 29, 2026 at 9:30 a.m. ET [PR Newswire, Honeywell Board Approves Spin-Off, June 15, 2026, Grade A]. The opening price is the first market test of the consensus ~$207/share SOTP valuation. If HONA clears at or below ~$175 on day one, the organic-growth-tier mechanism begins to register even before any reported data — but day-one price discovery alone is not a full convergence event because it reflects forced-seller pressure and index mechanics, not yet the growth data.

---

## 2. Causal Mechanism (four steps)

1. **Trigger event manifests the data.** HONA reports Q2 FY2026 results as a standalone company for the first time — organic revenue growth rate and cash from operations are disclosed as clean, separated figures for the first full quarter under HONA's own name. If organic growth comes in at 3–5% (consistent with Q1 2026's 3% print [Honeywell Q1 FY2026 8-K, SEC EDGAR, April 24, 2026]) and FCF conversion remains below 85% of EBITDA due to the $225M/year trademark licence fee and stranded overhead costs [Honeywell Aerospace Investor Day, June 3, 2026; divergentcapital7651.substack.com, June 2026, web unverified], the growth-tier mismatch and FCF-conversion deficit become reported facts on a separated-company income statement — not inferences from a combined-company filing.

2. **Consensus models and estimates update.** Analysts at Barclays (Overweight, $243 target as of June 2026) and Wells Fargo (Equal Weight, $220–$240 as of June 2026) — both of whom noted directional concern about cash flow and execution risk without publishing a growth-adjusted peer comparable — must now reconcile their models against the first standalone organic growth number and the first standalone FCF conversion rate [web searches, June 15, 2026, unverified]. Analysts who applied the full-peer-roster median of ~29x EV/EBITDA must justify that multiple against reported 3–5% organic growth, and any sell-side team that recalibrates toward the 17–21x range (matching Curtiss-Wright and mid-tier A&D peers at comparable growth rates) publishes a lower price target that anchors the market's view of fair value.

3. **Capital reallocates.** Event-driven and long-only funds that bought HONA into the spin-off expecting the consensus ~$207 SOTP to clear sell into the post-earnings weakness; generalist large-cap holders who were already reluctant to own an aerospace-only stock (the forced-seller population identified in M0.6.3) accelerate exits as the growth case fails to materialize at the top-tier peer level; value-oriented aerospace specialists who price HONA at 18–20x EV/EBITDA begin to set bids only at or below ~$144–160/share, creating a lower equilibrium.

4. **Price converges toward the variant view.** HONA's market price moves from the ~$207 consensus anchor toward the $144–160 range as the combination of lower analyst price targets, forced-seller clearing, and growth-rate-justified bid levels sets a new price equilibrium — closing the ~27% gap between the consensus SOTP and the growth-adjusted valuation the variant identified. This is not guaranteed to complete in one trading session; the convergence runs over the weeks following the earnings release as analyst model updates propagate and the forced-seller overhang clears (the M0.5 falsifier window closes September 7, 2026).

---

## 3. Secondary Triggers

| ID | Trigger | Date | Type | P | Mechanism (one line) |
|---|---|---|---|---:|---|
| ST-001 | HONA regular-way opening price on Nasdaq | June 29, 2026 | scheduled | null | If HONA opens materially below ~$175, the day-one price reveals that the market is not awarding the consensus 29x multiple even before reported data — partial convergence without confirming the organic-growth mechanism specifically. |
| ST-002 | Barclays or Wells Fargo publish a revised HONA price target with a growth-adjusted peer comparable set | No announced date; expected within 2–4 weeks of the June 29 listing, i.e. July 2026 | unscheduled | 0.45 | Initiation or target-cut research from either bank that explicitly ties HONA's applicable EV/EBITDA to the organic growth sub-group (rather than the full peer median) causes other analysts to adopt the same framework and compresses the consensus target, driving partial price convergence before the earnings release. Probability 0.45: both banks have flagged directional concern but have not published the specific mechanism; an initiation note is likely post-listing but the growth-adjusted framework is not confirmed [web search, June 15, 2026, unverified]. |
| ST-003 | HONA 10-Q filing (Form 10-Q, Q2 FY2026) | By August 9, 2026 (SEC 40-day filing deadline for large accelerated filers) | scheduled | null | If HONA files its 10-Q before it holds an earnings call, the FCF conversion and organic revenue growth figures become publicly available in the filing and trigger analyst model updates even before management commentary — same causal chain as the primary trigger but without the call narrative. |
| ST-004 | HON (Honeywell Technologies) Q2 FY2026 earnings call includes HONA-related commentary | Late July 2026 (same window as primary trigger) | scheduled | null | Honeywell Technologies reports its own Q2 results for the stub period post-separation; any commentary on the combined Honeywell Q2 run-rate for the period before separation reveals the organic growth trajectory and may prompt analysts to update HONA models in advance of HONA's own standalone release. |

---

## 4. Verdict

Verdict: trigger scheduled (late July 2026 — August 9, 2026 outer bound) — proven timing

The primary trigger is a legally mandated event (first standalone Form 10-Q / earnings release) with a hard outer deadline of August 9, 2026, comfortably inside the M0.4 September 7, 2026 expiry. The causal chain from earnings print to analyst model revision to capital reallocation to price convergence names specific actors (Barclays, Wells Fargo, event-driven and forced-seller holders) and specific data points (organic revenue growth rate, FCF conversion vs. the 85–95%+ premium-multiple benchmark). The exact earnings date is not yet published by HONA investor relations as of June 15, 2026, but the 40-day SEC filing rule makes the window certain. Secondary triggers provide partial convergence checkpoints starting June 29, 2026 (day-one price) and continuing through July (analyst initiation notes).
